Tuesday, May 18, 2010

Pfizer will be cutting 6,000 jobs

Pfizer Global Manufacturing Announces Plans To Reconfigure Its Global Plant Network
- - -
Eight Sites Targeted for Exit; Reductions Recommended At Six Plants; Operations to Expand at Others

NEW YORK, N.Y., May 18 - Pfizer Global Manufacturing announced today plans to reconfigure its worldwide plant network to create a fully aligned manufacturing and supply organization from the combined networks of Pfizer and Wyeth... These changes will result in a global reduction of approximately 6,000 jobs over the next several years.

Recommended Site Exits:
  • Caguas, Puerto Rico (solid-dose)
  • Carolina, Puerto Rico (aseptic)
  • Dublin, Ireland (aseptic)
  • Loughbeg, Ireland (solid-dose)
  • Shanbally, Ireland (biotechnology)
  • Rouses Point, N.Y. (solid-dose)
  • Richmond, Virginia (consumer healthcare manufacturing targeted for exit; R&D operations to remain in Richmond)
  • Pearl River, N.Y. (proposed exit of biotechnology and consumer healthcare manufacturing; vaccines and biotherapeutics vaccines R&D will remain active at this site)
Recommended Plant Reductions:
  • Guayama, Puerto Rico (phase-out of pharmaceutical solid dose operations planned; volume increases in consumer healthcare)
  • Newbridge, Ireland (solid-dose)
  • Andover, Mass., U.S. (biotechnology)
  • Sanford, N.C., U.S. (biotechnology)
  • Havant, UK (biotechnology)
  • Illertissen, Germany (solid-dose)
You can read the full press release here (PDF).

No comments:

Post a Comment